AI helps classify colon cancer tissue samples

By staff writers

June 29, 2020 -- Working with infrared (IR) microscopes based on quantum cascade lasers and artificial intelligence (AI) can enable accurate classification of colon cancer tissue samples in a marker-free and automated way, according to a research team from the Prodi Centre for Protein Diagnostics at Ruhr-Universität Bochum in Germany.

AI allowed the researchers to differentiate tumors that were microsatellite stable (MSS) from those with microsatellite instability (MSI) with great accuracy within approximately 30 minutes, according to a feasibility study reported June 23 in Scientific Reports.

Patients with MSI tumors have a significantly higher survival rate due to a mutation rate of cancer cells that is about 1,000 times higher, but also because they respond better to innovative immunotherapy.

Differential diagnosis has been carried out by immunohistochemical staining of tissue samples with subsequent complex genetic analysis. IR imaging as a diagnostic tool for the classification of tissue has already been used in earlier studies at the university. The method recognizes cancer tissue without prior staining or other marking and also works automatically with the aid of AI. Unlike conventional methods that generate a differential diagnosis in a day, IR imaging requires only about half an hour, the researchers noted.

In the study just reported, which involved 100 patients, the method showed a sensitivity of 100% and a specificity of 93%. All MSI tumors were correctly classified and only a few samples were falsely identified.

The researchers are starting an expanded clinical trial that will be carried out on samples from the Colopredict Plus 2.0 registry study. In the future, the method will be introduced into the clinical workflow to assess its potential for precision oncology.

Industry roundup: Oncology dominates noncoronavirus IVD news
There's no doubt that COVID-19 tests remain a focal point for IVD research and development. But companies increasingly are announcing new non-COVID-19...
AI performs well at assessing colon polyps on path images
An artificial intelligence (AI) system performed well at distinguishing four common types of polyps on digitized histopathologic slides. The findings...
Machine learning, tumor DNA testing a winning combo in colon cancer
A new machine-learning platform helped identify patients with colorectal cancer and predict disease severity with high accuracy in a study of circulating...
ACS finds colon cancer screening in 40s on the rise
Colon cancer screening among average-risk adults between the ages of 45 and 49 has been on the rise: It more than doubled in 2018, according to in-person...
ACP advises biennial -- not annual -- stool tests for colon cancer
In a debatable move, the American College of Physicians (ACP) advised biennial -- rather than annual -- testing of stool for signs of colorectal cancer...

Copyright © 2020

Last Updated ls 6/26/2020 4:51:42 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.